𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women

✍ Scribed by Block, S. L.; Nolan, T.; Sattler, C.; Barr, E.; Giacoletti, K. E.D.; Marchant, C. D.; Castellsague, X.; Rusche, S. A.; Lukac, S.; Bryan, J. T.; Cavanaugh, P. F.; Reisinger, K. S.

Book ID
123607018
Publisher
American Academy of Pediatrics
Year
2006
Tongue
English
Weight
409 KB
Volume
118
Category
Article
ISSN
0031-4005

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety, immunogenicity, and efficacy of
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women
✍ Gonzalo Perez; Eduardo Lazcano-Ponce; Mauricio Hernandez-Avila; Patricia J. Garc πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 103 KB

## Abstract The prevalence of HPV infection in Latin America is among the highest in the world. A quadrivalent (types 6/11/16/18) human papillomavirus L1 virus‐like‐particle vaccine has been shown to be 95–100% effective in preventing HPV 6/11/16/18‐related cervical and genital disease in women naΓ―